Brought to you by
ECR 2019 / C-2827
Certificate of Merit
Malignant pancreatic cystic lesions – is the imaging diagnosis accurate?
Congress: ECR 2019
Poster No.: C-2827
Type: Educational Exhibit
Keywords: Cancer, Education, Comparative studies, MR, CT, Abdomen
Authors: A. Dijmarescu, M. Buzoianu, C. Peneoasu, A. Serban, B. Cotruta, V. Herlea, M. Grasu, I. G. Lupescu; Bucharest/RO


  1. Pusateri AJ, Krishna SG: Pancreatic Cystic Lesions: Pathogenesis and Malignant Potential. Diseases. 2018 Jun 13;6(2)
  2. Nougaret S, Mannelli L, Pierredon MA, et al: Cystic pancreatic lesions: From increased diagnosis rate to new dilemmas, Diagn Interv Imaging, 2016, 97(12): 1275-1285
  3. Schmid RM, Siveke JT: Approach to cystic lesions of the pancreas. Wien Med Wochenschr. 2014 Feb;164(3-4):44-50
  4. Bauer F.: Pancreatic Cystic Lesions: Diagnostic, Management and Indications for Operation. Part I. Chirurgia (Bucur). 2017 Mar-Apr;112(2):97-109
  5. Jose Lariño-Noia, et al. EUS-FNA in cystic pancreatic lesions: Where are we now and where are we headed in the future? Endosc Ultrasound Apr 2018
  6. Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006
  7. Aune D, et al. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol. 2012
  8. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003
  9. Michaud DS, et al. Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan) Cancer Causes Control. 2010
  10. Li D, Tang H, Hassan MM, Holly EA, Bracci PM, Silverman DT. Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control. 2011
  11. Kudo Y, Kamisawa T, Anjiki H, Takuma K, Egawa N. Incidence of and risk factors for developing pancreatic cancer in patients with chronic pancreatitis. Hepatogastroenterology. 2011
  12. Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2012
  13. Kim HJ et-al. CT of serous cystadenoma of the pancreas and mimicking masses. AJR Am J Roentgenol. 2008
  14. Sahani D., et al: Cystic Pancreatic Lesions: A Simple Imaging-based Classification System for Guiding Management, RadioGraphics,  2005
  15. Kalb B., et al: MR Imaging of Cystic Lesions of the Pancreas, RadioGraphics, 2009
  16. Oneil N et al. Intraductal Papillary Mucinous Neoplasm of pancre as N Am J Med Sci 2015
  17. Roch AM et al. The natural history of main duct-involved, mixed-type intraductal papillary mucinous neoplasm: Parameters predictive of progression. Ann Surg. 2014 Oct
  18. Morales-Oyarvide V., Yoon W.J., Ingkakul T., et al: Cystic Pancreatic Neuroendocrine Tumors – The Value of Cytology in Preoperative Diagnosis, Cancer Cytopathol. 2014
  19. Caglia P., Cannizzaro M.T., Tracia A, et al: Cystic pancreatic neuroendocrine tumors: To date a diagnostic challenge, Int J Surg. 2015
  20. Tanaka M et al. International Association of Pancreatology. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012
  21. Tummala P, Junaidi O, Agarwal B. Imaging of pancreatic cancer: An overview. J Gastrointest Oncol. 2011
  22. Palmucci S, Trombatore C, Foti PV, Mauro LA, Milone P, Milazzotto R, et al. The utilization of imaging features in the management of intraductal papillary mucinous neoplasms. Gastroenterol Res Pract. 2014
  23. Kalra MK, Maher MM, Mueller PR et-al. State-of-the-art imaging of pancreatic neoplasms. Br J Radiol. 2003


POSTER ACTIONS Add bookmark Contact presenter Send to a friend Download pdf
2 clicks for more privacy: On the first click the button will be activated and you can then share the poster with a second click.

This website uses cookies. Learn more